30 tablets/ bottle
What is gefitinib?
Gefitinib is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Gefitinib is used to treat non-small cell lung cancer.
Gefitinib is sometimes used to treat cancer that has spread to other parts of the body.
Gefitinib dosing information
Usual Adult Dose for Non-Small Cell Lung Cancer:
250 mg orally once a day until disease progression or unacceptable toxicity
NOTE: For patients who have difficulty swallowing tablets immerse the tablet in 4 to 8 ounces of water (noncarbonated) and stir until dispersed (about 15 minutes). Drink the liquid or administer through a nasogastric tube. Rinse the container with 4 to 8 ounces of water and drink or administer through nasogastric tube.
-Select patients for the first-line treatment of metastatic NSCLC with this drug based on the presence of EGFR exon 19 deletions or exon 21 L858R mutations in their tumor or plasma specimens.
Use: For first-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
What other drugs will affect gefitinib?
Other drugs may interact with gefitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.